1. Startpage

Browsing by Author Galle, Peter R.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 29  next >
PreviewIssue dateOnline publication dateTitleAuthor(s)
biology_and_significance_of_a-20220620120208132.pdf.jpg201920-Jun-2022Biology and significance of alpha-fetoprotein in hepatocellular carcinomaGalle, Peter R.; Foerster, Friedrich; Kudo, Masatoshi; Chan, Stephen L.; Llovet, Josep M; Qin, Shukui; Schelman, William R.; Chintharlapalli, Sudhakar; Abada, Paolo B.; Sherman, Morris; Zhu, Andrew X.
burden_of_depression_and_anxi-20220822122501994.pdf.jpg202223-Aug-2022Burden of depression and anxiety disorders per disease codes in patients with lymphoma in GermanyTilch, Marie-Kristin; Galle, Peter R.; Schattenberg, Jörn M.; Kostev, Karel; Labenz, Christian
59415.pdf.jpg201911-Nov-2019Cardiovascular risk categories in patients with nonalcoholic fatty liver disease and the role of low-density lipoprotein cholesterolLabenz, Christian; Prochaska, Jürgen H.; Huber, Yvonne; Nagel, Michael; Straub, Beate; Wild, Philipp; Galle, Peter R.; Schattenberg, Jörn
cost_evaluation_of_pageb_risk-20220630121855371.pdf.jpg202130-Jun-2022Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis BSprinzl, Martin F.; Feist, Christina; Koch, Sandra; Kremer, Wolfgang Maximilian; Lackner, Karl J.; Weinmann, Arndt; Galle, Peter R.
diabetic_liver_injury_from_st-20220913193459567.pdf.jpg201314-Sep-2022Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cellsKohl, Tobias; Gehrke, Nadine; Schad, Arno; Nagel, Michael; Wörns, Marcus-Alexander; Sprinzl, Martin; Zimmermmann, Tim; He, You Wen; Galle, Peter R.; Schuchmann, Marcus; Schattenberg, Jörn
efficacy_and_safety_of_a_conv-20220714111608576.pdf.jpg201515-Jul-2022Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan® and Mowel® after liver transplantationVollmar, Johanna; Bellmann, Maren Christina; Darstein, Felix; Hoppe-Lotichius, Maria; Mittler, Jens; Heise, Michael; Rüttger, Bernd; Weyer, Veronika; Zimmermann, Anca; Lang, Hauke; Galle, Peter R.; Zimmermann, Tim
elevated_serum_levels_of_meth-20220815115004627.pdf.jpg202115-Aug-2022Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosisMichel, Maurice; Hess, Cornelius; Kaps, Leonard; Kremer, Wolfgang M.; Hilscher, Max; Galle, Peter R.; Moehler, Markus; Schattenberg, Jörn M.; Wörns, Marcus-Alexander; Labenz, Christian; Nagel, Michael
emerging_immunotherapy_for_hc-20230119115733564.pdf.jpg202219-Jan-2023Emerging immunotherapy for HCC : a guide for hepatologistsFoerster, Friedrich; Gairing, Simon Johannes; Ilyas, Sumera Irie; Galle, Peter R.
evaluation_of_a_laboratorybas-20220822134023960.pdf.jpg202123-Aug-2022Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admissionHäuser, Friederike; Sprinzl, Martin F.; Dreis, Kim J.; Renzaho, Angelique; Youhanen, Simon; Kremer, Wolfgang M.; Podlech, Jürgen; Galle, Peter R.; Lackner, Karl J.; Rossmann, Heidi; Lemmermann, Niels A.
healthrelated_quality_of_life-20220805150847806.pdf.jpg20219-Aug-2022Health-related quality of life in patients with autoimmune hepatitisMichel, Maurice; Spinelli, Francesca; Grambihler, Annette; Labenz, Christian; Nagel, Michael; Kaps, Leonard; Huber, Yvonne; Galle, Peter R.; Wörns, Marcus-Alexander; Schattenberg, Jörn M.
58508.pdf.jpg201817-Oct-2018The immune contexture of hepatocellular carcinoma predicts clinical outcomeFoerster, Friedrich; Hess, Moritz; Gerhold-Ay, Aslihan; Marquardt, Jens; Becker, Diana; Galle, Peter R.; Schuppan, Detlef; Binder, Harald; Bockamp, Ernesto
impact_of_thyroid_disorders_o-20221206100750093.pdf.jpg20216-Dec-2022Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in GermanyLabenz, Christian; Kostev, Karel; Armandi, Angelo; Galle, Peter R.; Schattenberg, Jörn M.
labenz_christian-incident_demen-20210826121540456.pdf.jpg202126-Aug-2021Incident dementia in elderly patients with nonalcoholic fatty liver disease in GermanyLabenz, Christian; Kostev, Karel; Kaps, Leonard; Galle, Peter R.; Schattenberg, Jörn M.
irritable_bowel_syndrome_and_-20220925163838020.pdf.jpg201317-Oct-2022Irritable bowel syndrome and organic diseases : a comparative analysis of esophageal motilityThomaidis, Thomas; Götz, Martin; Gregor, Sebastian; Hoffman, Arthur; Kouroumalis, Elias; Möhler, Markus; Galle, Peter R.; Schwarting, Andreas; Kiesslich, Ralf
ncadherin_distinguishes_intra-20230112135952723.pdf.jpg202213-Jan-2023N-cadherin distinguishes intrahepatic cholangiocarcinoma from liver metastases of ductal adenocarcinoma of the pancreasGerber, Tiemo S.; Goeppert, Benjamin; Hausen, Anne; Witzel, Hagen R.; Bartsch, Fabian; Schindeldecker, Mario; Gröger, Lisa-Katharina; Ridder, Dirk A.; Cahyadi, Oscar; Esposito, Irene; Gaida, Matthias M.; Schirmacher, Peter; Galle, Peter R.; Lang, Hauke; Roth, Wilfried; Straub, Beate K.
pathogenic_lipidbinding_antip-20220902174134868.pdf.jpg202112-Sep-2022Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19Hollerbach, Anne; Müller-Calleja, Nadine; Pedrosa, Denise; Canisius, Antje; Sprinzl, Martin F.; Falter, Tanja; Rossmann, Heidi; Bodenstein, Marc; Werner, Christian; Sagoschen, Ingo; Münzel, Thomas; Schreiner, Oliver; Sivanathan, Visvakanth; Reuter, Michael; Niermann, Johannes; Galle, Peter R.; Teyton, Luc; Ruf, Wolfram; Lackner, Karl J.
mähringer-kunz_aline-predicting_sur-20210826101204684.pdf.jpg202026-Aug-2021Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network : a pilot studyMähringer-Kunz, Aline; Wagner, Franziska; Hahn, Felix; Weinmann, Arndt; Brodehl, Sebastian; Schotten, Sebastian; Hinrichs, Jan B.; Düber, Christoph; Galle, Peter R.; Pinto dos Santos, Daniel; Kloeckner, Roman
prevalence_and_clinical_signi-20221201094912961.pdf.jpg20221-Dec-2022Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationMüller, Lukas; Hahn, Felix; Mähringer-Kunz, Aline; Stoehr, Fabian; Gairing, Simon Johannes; Foerster, Friedrich; Weinmann, Arndt; Galle, Peter R.; Mittler, Jens; Pinto dos Santos, Daniel; Pitton, Michael Bernhard; Düber, Christoph; Fehrenbach, Uli; Auer, Timo Alexander; Gebauer, Bernhard; Kloeckner, Roman
ramucirumab_in_patients_with_-20220902173054571.pdf.jpg20217-Sep-2022Ramucirumab in patients with previously treated advanced hepatocellular carcinoma : impact of liver disease aetiologyGalle, Peter R.; Kudo, Masatoshi; Llovet, Josep M.; Finn, Richard S.; Karwal, Mark; Pezet, Denis; Kim, Tae-You; Yang, Tsai-Sheng; Lonardi, Sara; Tomasek, Jiri; Phelip, Jean-Marc; Touchefeu, Yann; Koh, Su-Jin; Stirnimann, Guido; Liang, Kun; Ogburn, Kenyon D.; Wang, Chunxiao; Abada, Paolo; Widau, Ryan C.; Zhu, Andrew X.
review_article__posttipss_hep-20230123094120726.pdf.jpg202223-Jan-2023Review article: post-TIPSS hepatic encephalopathy—current knowledge and future perspectivesGairing, Simon Johannes; Müller, Lukas; Kloeckner, Roman; Galle, Peter R.; Labenz, Christian
Showing results 1 to 20 of 29  next >